Literature DB >> 8707279

Elevated aflatoxin exposure and increased risk of hepatocellular carcinoma.

C J Chen1, L Y Wang, S N Lu, M H Wu, S L You, Y J Zhang, L W Wang, R M Santella.   

Abstract

To elucidate the importance of aflatoxin in the etiology of hepatocellular carcinoma (HCC), a community-based cohort study combined with molecular dosimetry of aflatoxin exposure was performed in the Penghu Islets where the HCC mortality rate is highest in Taiwan. A total of 6,487 residents aged 30 to 65 years were recruited in the two-stage screening survey and underwent regular follow-up examination. Among 33 newly diagnosed HCC cases, 31 (94%) were chronic hepatitis B surface antigen (HBsAg) carriers and 3 (9%) were positive for antibodies against hepatitis C virus (HCV). Among 20 HCC patients and 86 matched healthy controls whose serum samples were tested for aflatoxin B1 (AFB1)-albumin adducts by competitive enzyme-linked immunosorbant assay (ELISA), 13 (65%) HCC patients and 32 (37%) matched controls were seropositive, showing a statistically significant multivariate-adjusted odds ratio of 5.5 with a 95% confidence interval of 1.2 to 24.5. The results imply the elevated risk of HCC among Penghu residents may be attributable to their heavy exposure to aflatoxins and high HBsAg carrier rate.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8707279     DOI: 10.1002/hep.510240108

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  46 in total

1.  Chemopreventive effect of oltipraz on AFB(1)-induced hepatocarcinogenesis in tree shrew model.

Authors:  Yuan Li; Jian-Jia Su; Liu-Liang Qin; Chun Yang; Dan Luo; Ke-Chen Ban; TW Kensler; BD Roebuck
Journal:  World J Gastroenterol       Date:  2000-10       Impact factor: 5.742

Review 2.  Population attributable risk of aflatoxin-related liver cancer: systematic review and meta-analysis.

Authors:  Yan Liu; Chung-Chou H Chang; Gary M Marsh; Felicia Wu
Journal:  Eur J Cancer       Date:  2012-03-08       Impact factor: 9.162

3.  Interactions of chemical carcinogens and genetic variation in hepatocellular carcinoma.

Authors:  Yu-Jing Zhang
Journal:  World J Hepatol       Date:  2010-03-27

4.  Homozygosity for Pro of p53 Arg72Pro as a potential risk factor for hepatocellular carcinoma in Chinese population.

Authors:  Zhong-Zheng Zhu; Wen-Ming Cong; Shu-Fang Liu; Hui Dong; Guan-Shan Zhu; Meng-Chao Wu
Journal:  World J Gastroenterol       Date:  2005-01-14       Impact factor: 5.742

5.  Development of hepatocellular carcinoma in a patient with Crohn's disease treated with azathioprine.

Authors:  Jason Samarasena; Mark Borgaonkar
Journal:  Dig Dis Sci       Date:  2007-04-03       Impact factor: 3.199

6.  Differences in characteristics of patients with and without known risk factors for hepatocellular carcinoma in the United States.

Authors:  Jon D Dorfman; Richard Schulick; Michael A Choti; Jean-Francois H Geschwind; Ihab Kamel; Michael Torbenson; Paul J Thuluvath
Journal:  World J Gastroenterol       Date:  2007-02-07       Impact factor: 5.742

7.  Associated factors in modulating aflatoxin B1-albumin adduct level in three Chinese populations.

Authors:  Peng Tao; Liu Zhi-Ming; Liu Tang-Wei; Li Le-Qun; Peng Min-Hao; Qin Xue; Yan Lu-Nam; Liang Ren-Xiang; Wei Zong-Liang; Wang Lian-Wen; Wang Qiao; Shen Han-Ming; Ong Choon-Nam; Regina M Santella
Journal:  Dig Dis Sci       Date:  2005-03       Impact factor: 3.199

8.  Changing rates for liver and lung cancers in Qidong, China.

Authors:  Jian-Guo Chen; Thomas W Kensler
Journal:  Chem Res Toxicol       Date:  2013-11-20       Impact factor: 3.739

9.  Impact of country of birth on age at the time of diagnosis of hepatocellular carcinoma in the United States.

Authors:  Ju Dong Yang; Sean F Altekruse; Mindie H Nguyen; Gregory J Gores; Lewis R Roberts
Journal:  Cancer       Date:  2016-08-29       Impact factor: 6.860

10.  Hepatitis B virus infection contributes to oxidative stress in a population exposed to aflatoxin B1 and high-risk for hepatocellular carcinoma.

Authors:  Zhi-Ming Liu; Le-Qun Li; Min-Hao Peng; Tang-Wei Liu; Zhong Qin; Ya Guo; Kai-Yin Xiao; Xin-Ping Ye; Xin-Shao Mo; Xue Qin; Shan Li; Lu-Nan Yan; Han-Ming Shen; LianWen Wang; Qiao Wang; Kai-bo Wang; Ren-xiang Liang; Zong-liang Wei; Choon Nam Ong; Regina M Santella; Tao Peng
Journal:  Cancer Lett       Date:  2008-02-15       Impact factor: 8.679

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.